{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T02:52:23Z","timestamp":1777517543971,"version":"3.51.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T00:00:00Z","timestamp":1560902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T00:00:00Z","timestamp":1560902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1038\/s41416-019-0492-8","type":"journal-article","created":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T23:14:13Z","timestamp":1560899653000},"page":"180-192","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers"],"prefix":"10.1038","volume":"121","author":[{"name":"KConFab Investigators","sequence":"first","affiliation":[]},{"given":"Frank","family":"Qian","sequence":"first","affiliation":[]},{"name":"HEBON Investigators","sequence":"additional","affiliation":[]},{"name":"GEMO Study Collaborators","sequence":"additional","affiliation":[]},{"name":"EMBRACE Collaborators","sequence":"additional","affiliation":[]},{"name":"on behalf of CIMBA","sequence":"additional","affiliation":[]},{"given":"Matti A.","family":"Rookus","sequence":"additional","affiliation":[]},{"given":"Goska","family":"Leslie","sequence":"additional","affiliation":[]},{"given":"Harvey A.","family":"Risch","sequence":"additional","affiliation":[]},{"given":"Mark H.","family":"Greene","sequence":"additional","affiliation":[]},{"given":"Cora M.","family":"Aalfs","sequence":"additional","affiliation":[]},{"given":"Muriel A.","family":"Adank","sequence":"additional","affiliation":[]},{"given":"Julian","family":"Adlard","sequence":"additional","affiliation":[]},{"given":"Bjarni A.","family":"Agnarsson","sequence":"additional","affiliation":[]},{"given":"Munaza","family":"Ahmed","sequence":"additional","affiliation":[]},{"given":"Kristiina","family":"Aittom\u00e4ki","sequence":"additional","affiliation":[]},{"given":"Irene L.","family":"Andrulis","sequence":"additional","affiliation":[]},{"given":"Norbert","family":"Arnold","sequence":"additional","affiliation":[]},{"given":"Banu K.","family":"Arun","sequence":"additional","affiliation":[]},{"given":"Margreet G. E. M.","family":"Ausems","sequence":"additional","affiliation":[]},{"given":"Jacopo","family":"Azzollini","sequence":"additional","affiliation":[]},{"given":"Daniel","family":"Barrowdale","sequence":"additional","affiliation":[]},{"given":"Julian","family":"Barwell","sequence":"additional","affiliation":[]},{"given":"Javier","family":"Benitez","sequence":"additional","affiliation":[]},{"given":"Katarzyna","family":"Bia\u0142kowska","sequence":"additional","affiliation":[]},{"given":"Val\u00e9rie","family":"Bonadona","sequence":"additional","affiliation":[]},{"given":"Julika","family":"Borde","sequence":"additional","affiliation":[]},{"given":"Ake","family":"Borg","sequence":"additional","affiliation":[]},{"given":"Angela R.","family":"Bradbury","sequence":"additional","affiliation":[]},{"given":"Joan","family":"Brunet","sequence":"additional","affiliation":[]},{"given":"Saundra S.","family":"Buys","sequence":"additional","affiliation":[]},{"given":"Trinidad","family":"Cald\u00e9s","sequence":"additional","affiliation":[]},{"given":"Maria A.","family":"Caligo","sequence":"additional","affiliation":[]},{"given":"Ian","family":"Campbell","sequence":"additional","affiliation":[]},{"given":"Jonathan","family":"Carter","sequence":"additional","affiliation":[]},{"given":"Jocelyne","family":"Chiquette","sequence":"additional","affiliation":[]},{"given":"Wendy K.","family":"Chung","sequence":"additional","affiliation":[]},{"given":"Kathleen B. M.","family":"Claes","sequence":"additional","affiliation":[]},{"given":"J. Margriet","family":"Coll\u00e9e","sequence":"additional","affiliation":[]},{"given":"Marie-Agn\u00e8s","family":"Collonge-Rame","sequence":"additional","affiliation":[]},{"given":"Fergus J.","family":"Couch","sequence":"additional","affiliation":[]},{"given":"Mary B.","family":"Daly","sequence":"additional","affiliation":[]},{"given":"Capucine","family":"Delnatte","sequence":"additional","affiliation":[]},{"given":"Orland","family":"Diez","sequence":"additional","affiliation":[]},{"given":"Susan M.","family":"Domchek","sequence":"additional","affiliation":[]},{"given":"Cecilia M.","family":"Dorfling","sequence":"additional","affiliation":[]},{"given":"Jacqueline","family":"Eason","sequence":"additional","affiliation":[]},{"given":"Douglas F.","family":"Easton","sequence":"additional","affiliation":[]},{"given":"Ros","family":"Eeles","sequence":"additional","affiliation":[]},{"given":"Christoph","family":"Engel","sequence":"additional","affiliation":[]},{"given":"D. Gareth","family":"Evans","sequence":"additional","affiliation":[]},{"given":"Laurence","family":"Faivre","sequence":"additional","affiliation":[]},{"given":"Lidia","family":"Feliubadal\u00f3","sequence":"additional","affiliation":[]},{"given":"Lenka","family":"Foretova","sequence":"additional","affiliation":[]},{"given":"Eitan","family":"Friedman","sequence":"additional","affiliation":[]},{"given":"Debra","family":"Frost","sequence":"additional","affiliation":[]},{"given":"Patricia A.","family":"Ganz","sequence":"additional","affiliation":[]},{"given":"Judy","family":"Garber","sequence":"additional","affiliation":[]},{"given":"Vanesa","family":"Garcia-Barberan","sequence":"additional","affiliation":[]},{"given":"Andrea","family":"Gehrig","sequence":"additional","affiliation":[]},{"given":"Gord","family":"Glendon","sequence":"additional","affiliation":[]},{"given":"Andrew K.","family":"Godwin","sequence":"additional","affiliation":[]},{"given":"Encarna B.","family":"G\u00f3mez Garcia","sequence":"additional","affiliation":[]},{"given":"Ute","family":"Hamann","sequence":"additional","affiliation":[]},{"given":"Jan","family":"Hauke","sequence":"additional","affiliation":[]},{"given":"John L.","family":"Hopper","sequence":"additional","affiliation":[]},{"given":"Peter J.","family":"Hulick","sequence":"additional","affiliation":[]},{"given":"Evgeny N.","family":"Imyanitov","sequence":"additional","affiliation":[]},{"given":"Claudine","family":"Isaacs","sequence":"additional","affiliation":[]},{"given":"Louise","family":"Izatt","sequence":"additional","affiliation":[]},{"given":"Anna","family":"Jakubowska","sequence":"additional","affiliation":[]},{"given":"Ramunas","family":"Janavicius","sequence":"additional","affiliation":[]},{"given":"Esther M.","family":"John","sequence":"additional","affiliation":[]},{"given":"Beth Y.","family":"Karlan","sequence":"additional","affiliation":[]},{"given":"Carolien M.","family":"Kets","sequence":"additional","affiliation":[]},{"given":"Yael","family":"Laitman","sequence":"additional","affiliation":[]},{"given":"Conxi","family":"L\u00e1zaro","sequence":"additional","affiliation":[]},{"given":"Dominique","family":"Leroux","sequence":"additional","affiliation":[]},{"given":"Jenny","family":"Lester","sequence":"additional","affiliation":[]},{"given":"Fabienne","family":"Lesueur","sequence":"additional","affiliation":[]},{"given":"Jennifer T.","family":"Loud","sequence":"additional","affiliation":[]},{"given":"Jan","family":"Lubi\u0144ski","sequence":"additional","affiliation":[]},{"given":"Alicja","family":"\u0141ukomska","sequence":"additional","affiliation":[]},{"given":"Lesley","family":"McGuffog","sequence":"additional","affiliation":[]},{"given":"Noura","family":"Mebirouk","sequence":"additional","affiliation":[]},{"given":"Hanne E. J.","family":"Meijers-Heijboer","sequence":"additional","affiliation":[]},{"given":"Alfons","family":"Meindl","sequence":"additional","affiliation":[]},{"given":"Austin","family":"Miller","sequence":"additional","affiliation":[]},{"given":"Marco","family":"Montagna","sequence":"additional","affiliation":[]},{"given":"Thea M.","family":"Mooij","sequence":"additional","affiliation":[]},{"given":"Emmanuelle","family":"Mouret-Fourme","sequence":"additional","affiliation":[]},{"given":"Katherine L.","family":"Nathanson","sequence":"additional","affiliation":[]},{"given":"Bita","family":"Nehoray","sequence":"additional","affiliation":[]},{"given":"Susan L.","family":"Neuhausen","sequence":"additional","affiliation":[]},{"given":"Heli","family":"Nevanlinna","sequence":"additional","affiliation":[]},{"given":"Finn C.","family":"Nielsen","sequence":"additional","affiliation":[]},{"given":"Kenneth","family":"Offit","sequence":"additional","affiliation":[]},{"given":"Edith","family":"Olah","sequence":"additional","affiliation":[]},{"given":"Kai-ren","family":"Ong","sequence":"additional","affiliation":[]},{"given":"Jan C.","family":"Oosterwijk","sequence":"additional","affiliation":[]},{"given":"Laura","family":"Ottini","sequence":"additional","affiliation":[]},{"given":"Michael T.","family":"Parsons","sequence":"additional","affiliation":[]},{"given":"Paolo","family":"Peterlongo","sequence":"additional","affiliation":[]},{"given":"Georg","family":"Pfeiler","sequence":"additional","affiliation":[]},{"given":"Nisha","family":"Pradhan","sequence":"additional","affiliation":[]},{"given":"Paolo","family":"Radice","sequence":"additional","affiliation":[]},{"given":"Susan J.","family":"Ramus","sequence":"additional","affiliation":[]},{"given":"Johanna","family":"Rantala","sequence":"additional","affiliation":[]},{"given":"Gad","family":"Rennert","sequence":"additional","affiliation":[]},{"given":"Mark","family":"Robson","sequence":"additional","affiliation":[]},{"given":"Gustavo C.","family":"Rodriguez","sequence":"additional","affiliation":[]},{"given":"Ritu","family":"Salani","sequence":"additional","affiliation":[]},{"given":"Maren T.","family":"Scheuner","sequence":"additional","affiliation":[]},{"given":"Rita K.","family":"Schmutzler","sequence":"additional","affiliation":[]},{"given":"Payal D.","family":"Shah","sequence":"additional","affiliation":[]},{"given":"Lucy E.","family":"Side","sequence":"additional","affiliation":[]},{"given":"Jacques","family":"Simard","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1294-0027","authenticated-orcid":false,"given":"Christian F.","family":"Singer","sequence":"additional","affiliation":[]},{"given":"Doris","family":"Steinemann","sequence":"additional","affiliation":[]},{"given":"Dominique","family":"Stoppa-Lyonnet","sequence":"additional","affiliation":[]},{"given":"Yen Yen","family":"Tan","sequence":"additional","affiliation":[]},{"given":"Manuel R.","family":"Teixeira","sequence":"additional","affiliation":[]},{"given":"Mary Beth","family":"Terry","sequence":"additional","affiliation":[]},{"given":"Mads","family":"Thomassen","sequence":"additional","affiliation":[]},{"given":"Marc","family":"Tischkowitz","sequence":"additional","affiliation":[]},{"given":"Silvia","family":"Tognazzo","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0271-1792","authenticated-orcid":false,"given":"Amanda E.","family":"Toland","sequence":"additional","affiliation":[]},{"given":"Nadine","family":"Tung","sequence":"additional","affiliation":[]},{"given":"Christi J.","family":"van Asperen","sequence":"additional","affiliation":[]},{"given":"Klaartje","family":"van Engelen","sequence":"additional","affiliation":[]},{"given":"Elizabeth J.","family":"van Rensburg","sequence":"additional","affiliation":[]},{"given":"Laurence","family":"Venat-Bouvet","sequence":"additional","affiliation":[]},{"given":"Jeroen","family":"Vierstraete","sequence":"additional","affiliation":[]},{"given":"Gabriel","family":"Wagner","sequence":"additional","affiliation":[]},{"given":"Lisa","family":"Walker","sequence":"additional","affiliation":[]},{"given":"Jeffrey N.","family":"Weitzel","sequence":"additional","affiliation":[]},{"given":"Drakoulis","family":"Yannoukakos","sequence":"additional","affiliation":[]},{"given":"Antonis C.","family":"Antoniou","sequence":"additional","affiliation":[]},{"given":"David E.","family":"Goldgar","sequence":"additional","affiliation":[]},{"given":"Olufunmilayo I.","family":"Olopade","sequence":"additional","affiliation":[]},{"given":"Georgia","family":"Chenevix-Trench","sequence":"additional","affiliation":[]},{"given":"Timothy R.","family":"Rebbeck","sequence":"additional","affiliation":[]},{"given":"Dezheng","family":"Huo","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,6,19]]},"reference":[{"key":"492_CR1","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1080\/10937400701876095","volume":"11","author":"F Salehi","year":"2008","unstructured":"Salehi, F., Dunfield, L., Phillips, K. P., Krewski, D. Vanderhyden, B. C. Risk factors for ovarian cancer: an overview with emphasis on hormonal factors. J. Toxicol. Environ. Health B Crit. Rev. 11, 301\u2013321 (2008).","journal-title":"J. Toxicol. Environ. Health B Crit. Rev."},{"key":"492_CR2","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1200\/JCO.2016.66.8178","volume":"34","author":"N Wentzensen","year":"2016","unstructured":"Wentzensen, N., Poole, E. M., Trabert, B., White, E., Arslan, A. A., Patel, A. V. et al. Ovarian cancer risk factors by histologic subtype: an analysis from the Ovarian Cancer Cohort Consortium. J. Clin. Oncol. 34, 2888\u20132898 (2016).","journal-title":"J. Clin. Oncol."},{"key":"492_CR3","first-page":"15","volume":"4","author":"JA Rauh-Hain","year":"2011","unstructured":"Rauh-Hain, J. A., Krivak, T. C., Del Carmen, M. G., Olawaiye, A. B. Ovarian cancer screening and early detection in the general population. Rev. Obstet. Gynecol. 4, 15\u201321 (2011).","journal-title":"Rev. Obstet. Gynecol."},{"key":"492_CR4","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/S0140-6736(15)01224-6","volume":"387","author":"IJ Jacobs","year":"2016","unstructured":"Jacobs, I. J., Menon, U., Ryan, A., Gentry-Maharaj, A., Burnell, M., Kalsi, J. K. et al. Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. Lancet 387, 945\u2013956 (2016).","journal-title":"Lancet"},{"key":"492_CR5","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1177\/1758834017714993","volume":"9","author":"RT Neff","year":"2017","unstructured":"Neff, R. T., Senter, L. Salani, R. BRCA mutation in ovarian cancer: testing, implications and treatment considerations. Ther. Adv. Med. Oncol. 9, 519\u2013531 (2017).","journal-title":"Ther. Adv. Med. Oncol."},{"key":"492_CR6","doi-asserted-by":"crossref","unstructured":"King, M. C., Marks, J. H., Mandell, J. B. & New York Breast Cancer Study Group. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302, 643\u2013646 (2003).","DOI":"10.1126\/science.1088759"},{"key":"492_CR7","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","volume":"317","author":"KB Kuchenbaecker","year":"2017","unstructured":"Kuchenbaecker, K. B., Hopper, J. L., Barnes, D. R., Phillips, K. A., Mooij, T. M., Roos-Blom, M. J. et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 317, 2402\u20132416 (2017).","journal-title":"JAMA"},{"key":"492_CR8","doi-asserted-by":"publisher","unstructured":"Friebel, T. M., Domchek, S. M. & Rebbeck, T. R. Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis. J. Natl Cancer Inst. 106, https:\/\/doi.org\/10.1093\/jnci\/dju091 (2014).","DOI":"10.1093\/jnci\/dju091"},{"key":"492_CR9","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1086\/302583","volume":"65","author":"SA Gayther","year":"1999","unstructured":"Gayther, S. A., Russell, P., Harrington, P., Antoniou, A. C., Easton, D. F. Ponder, B. A. The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer: no evidence for other ovarian cancer-susceptibility genes. Am. J. Hum. Genet. 65, 1021\u20131029 (1999).","journal-title":"Am. J. Hum. Genet."},{"key":"492_CR10","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/nature09410","volume":"467","author":"H Lango Allen","year":"2010","unstructured":"Lango Allen, H., Estrada, K., Lettre, G., Berndt, S. I., Weedon, M. N., Rivadeneira, F. et al. Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 467, 832\u2013838 (2010).","journal-title":"Nature"},{"key":"492_CR11","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature14177","volume":"518","author":"AE Locke","year":"2015","unstructured":"Locke, A. E., Kahali, B., Berndt, S. I., Justice, A. E., Pers, T. H., Day, F. R. et al. Genetic studies of body mass index yield new insights for obesity biology. Nature 518, 197\u2013206 (2015).","journal-title":"Nature"},{"key":"492_CR12","doi-asserted-by":"publisher","first-page":"e1001200","DOI":"10.1371\/journal.pmed.1001200","volume":"9","author":"Collaborative Group on Epidemiological Studies of Ovarian Cancer.","year":"2012","unstructured":"Collaborative Group on Epidemiological Studies of Ovarian Cancer. Ovarian cancer and body size: individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies. PLoS Med. 9, e1001200 (2012).","journal-title":"PLoS Med."},{"key":"492_CR13","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1093\/jn\/136.11.2881","volume":"136","author":"GP Beehler","year":"2006","unstructured":"Beehler, G. P., Sekhon, M., Baker, J. A., Teter, B. E., McCann, S. E., Rodabaugh, K. J. et al. Risk of ovarian cancer associated with BMI varies by menopausal status. J. Nutr. 136, 2881\u20132886 (2006).","journal-title":"J. Nutr."},{"key":"492_CR14","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1093\/ije\/dyw158","volume":"45","author":"SC Dixon","year":"2016","unstructured":"Dixon, S. C., Nagle, C. M., Thrift, A. P., Pharoah, P. D., Pearce, C. L., Zheng, W. et al. Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study. Int. J. Epidemiol. 45, 884\u2013895 (2016).","journal-title":"Int. J. Epidemiol."},{"key":"492_CR15","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/S0140-6736(14)60892-8","volume":"384","author":"K Bhaskaran","year":"2014","unstructured":"Bhaskaran, K., Douglas, I., Forbes, H., dos-Santos-Silva, I., Leon, D. A. Smeeth, L. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults. Lancet 384, 755\u2013765 (2014).","journal-title":"Lancet"},{"key":"492_CR16","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1530\/ERC-12-0395","volume":"20","author":"CM Olsen","year":"2013","unstructured":"Olsen, C. M., Nagle, C. M., Whiteman, D. C., Ness, R., Pearce, C. L., Pike, M. C. et al. Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium. Endocr. Relat. Cancer 20, 251\u2013262 (2013).","journal-title":"Endocr. Relat. Cancer"},{"key":"492_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/srep04026","volume":"4","author":"JM Cunningham","year":"2014","unstructured":"Cunningham, J. M., Cicek, M. S., Larson, N. B., Davila, J., Wang, C., Larson, M. C. et al. Clinical characteristics of ovarian cancer classified by BRCA1, BRCA2, and RAD51C status. Sci. Rep. 4, 4026 (2014).","journal-title":"Sci. Rep."},{"key":"492_CR18","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/oby.2011.394","volume":"20","author":"J McGee","year":"2012","unstructured":"McGee, J., Kotsopoulos, J., Lubinski, J., Lynch, H. T., Rosen, B., Tung, N. et al. Anthropometric measures and risk of ovarian cancer among BRCA1 and BRCA2 mutation carriers. Obesity (Silver Spring) 20, 1288\u20131292 (2012).","journal-title":"Obesity (Silver Spring)"},{"key":"492_CR19","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess, S., Butterworth, A. Thompson, S. G. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet. Epidemiol. 37, 658\u2013665 (2013).","journal-title":"Genet. Epidemiol."},{"key":"492_CR20","doi-asserted-by":"publisher","first-page":"e1006944","DOI":"10.1371\/journal.pgen.1006944","volume":"13","author":"L Paternoster","year":"2017","unstructured":"Paternoster, L., Tilling, K. Davey Smith, G. Genetic epidemiology and Mendelian randomization for informing disease therapeutics: conceptual and methodological challenges. PLoS Genet. 13, e1006944 (2017).","journal-title":"PLoS Genet."},{"key":"492_CR21","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/EDE.0000000000000081","volume":"25","author":"TJ VanderWeele","year":"2014","unstructured":"VanderWeele, T. J., Tchetgen Tchetgen, E. J., Cornelis, M. Kraft, P. Methodological challenges in mendelian randomization. Epidemiology 25, 427\u2013435 (2014).","journal-title":"Epidemiology"},{"key":"492_CR22","doi-asserted-by":"publisher","first-page":"e1003212","DOI":"10.1371\/journal.pgen.1003212","volume":"9","author":"FJ Couch","year":"2013","unstructured":"Couch, F. J., Wang, X., McGuffog, L., Lee, A., Olswold, C., Kuchenbaecker, K. B. et al. Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. PLoS Genet. 9, e1003212 (2013).","journal-title":"PLoS Genet."},{"key":"492_CR23","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1001\/jama.2014.5985","volume":"313","author":"TR Rebbeck","year":"2015","unstructured":"Rebbeck, T. R., Mitra, N., Wan, F., Sinilnikova, O. M., Healey, S., McGuffog, L. et al. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. JAMA 313, 1347\u20131361 (2015).","journal-title":"JAMA"},{"issue":"4","key":"492_CR24","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1093\/jnci\/djy132","volume":"111","author":"Frank Qian","year":"2018","unstructured":"Qian, F., Wang, S., Mitchell, J., McGuffog, L., Barrowdale, D., Leslie, G. et al. Height and body mass index as modifiers of breast cancer risk in BRCA1\/2 mutation carriers: a Mendelian randomization study. J. Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/djy132 (2018).","journal-title":"JNCI: Journal of the National Cancer Institute"},{"key":"492_CR25","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/ng.3097","volume":"46","author":"AR Wood","year":"2014","unstructured":"Wood, A. R., Esko, T., Yang, J., Vedantam, S., Pers, T. H., Gustafsson, S. et al. Defining the role of common variation in the genomic and biological architecture of adult human height. Nat. Genet. 46, 1173\u20131186 (2014).","journal-title":"Nat. Genet."},{"key":"492_CR26","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou, A., Pharoah, P. D., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L. et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am. J. Hum. Genet. 72, 1117\u20131130 (2003).","journal-title":"Am. J. Hum. Genet."},{"key":"492_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/gepi.20074","volume":"29","author":"AC Antoniou","year":"2005","unstructured":"Antoniou, A. C., Goldgar, D. E., Andrieu, N., Chang-Claude, J., Brohet, R., Rookus, M. A. et al. A weighted cohort approach for analysing factors modifying disease risks in carriers of high-risk susceptibility genes. Genet Epidemiol. 29, 1\u201311 (2005).","journal-title":"Genet Epidemiol."},{"key":"492_CR28","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.annepidem.2006.02.001","volume":"16","author":"LE Bautista","year":"2006","unstructured":"Bautista, L. E., Smeeth, L., Hingorani, A. D. Casas, J. P. Estimation of bias in nongenetic observational studies using \u201cmendelian triangulation\u201d. Ann. Epidemiol. 16, 675\u2013680 (2006).","journal-title":"Ann. Epidemiol."},{"key":"492_CR29","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden, J., Davey Smith, G. Burgess, S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int. J. Epidemiol. 44, 512\u2013525 (2015).","journal-title":"Int. J. Epidemiol."},{"key":"492_CR30","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jhealeco.2007.09.009","volume":"27","author":"JV Terza","year":"2008","unstructured":"Terza, J. V., Basu, A. Rathouz, P. J. Two-stage residual inclusion estimation: addressing endogeneity in health econometric modeling. J. Health Econ. 27, 531\u2013543 (2008).","journal-title":"J. Health Econ."},{"key":"492_CR31","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.molonc.2009.02.001","volume":"3","author":"SJ Ramus","year":"2009","unstructured":"Ramus, S. J. Gayther, S. A. The contribution of BRCA1 and BRCA2 to ovarian cancer. Mol. Oncol. 3, 138\u2013150 (2009).","journal-title":"Mol. Oncol."},{"key":"492_CR32","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.ygyno.2017.10.001","volume":"147","author":"MR Jones","year":"2017","unstructured":"Jones, M. R., Kamara, D., Karlan, B. Y., Pharoah, P. D. P. Gayther, S. A. Genetic epidemiology of ovarian cancer and prospects for polygenic risk prediction. Gynecol. Oncol. 147, 705\u2013713 (2017).","journal-title":"Gynecol. Oncol."},{"key":"492_CR33","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1136\/bmj.39367.495995.AE","volume":"335","author":"GK Reeves","year":"2007","unstructured":"Reeves, G. K., Pirie, K., Beral, V., Green, J., Spencer, E., Bull, D. et al. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 335, 1134 (2007).","journal-title":"BMJ"},{"key":"492_CR34","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1093\/ije\/dyw129","volume":"45","author":"C Gao","year":"2016","unstructured":"Gao, C., Patel, C. J., Michailidou, K., Peters, U., Gong, J., Schildkraut, J. et al. Mendelian randomization study of adiposity-related traits and risk of breast, ovarian, prostate, lung and colorectal cancer. Int. J. Epidemiol. 45, 896\u2013908 (2016).","journal-title":"Int. J. Epidemiol."},{"key":"492_CR35","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1093\/jjco\/hyv080","volume":"45","author":"Z Liu","year":"2015","unstructured":"Liu, Z., Zhang, T. T., Zhao, J. J., Qi, S. F., Du, P., Liu, D. W. et al. The association between overweight, obesity and ovarian cancer: a meta-analysis. Jpn. J. Clin. Oncol. 45, 1107\u20131115 (2015).","journal-title":"Jpn. J. Clin. Oncol."},{"key":"492_CR36","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1158\/1055-9965.EPI-07-2524","volume":"17","author":"LJ Schouten","year":"2008","unstructured":"Schouten, L. J., Rivera, C., Hunter, D. J., Spiegelman, D., Adami, H. O., Arslan, A. et al. Height, body mass index, and ovarian cancer: a pooled analysis of 12 cohort studies. Cancer Epidemiol. Biomark. Prev. 17, 902\u2013912 (2008).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"492_CR37","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1002\/ijc.24952","volume":"126","author":"PH Lahmann","year":"2010","unstructured":"Lahmann, P. H., Cust, A. E., Friedenreich, C. M., Schulz, M., Lukanova, A., Kaaks, R. et al. Anthropometric measures and epithelial ovarian cancer risk in the European Prospective Investigation into Cancer and Nutrition. Int. J. Cancer 126, 2404\u20132415 (2010).","journal-title":"Int. J. Cancer"},{"key":"492_CR38","unstructured":"Cook, L. S., Meisner, A. L. W. & Weiss, N. S. in Cancer Epidemiolgy and Prevention, 4th edn. (eds Thun, M. J., Linet, M. S., Cerhan, J. R., Haiman, C. A., David Schottenfeld, D.) Ch. 47 (Oxford University Press, Oxford, 2018)."},{"key":"492_CR39","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/s41416-018-0011-3","volume":"118","author":"SC Dixon-Suen","year":"2018","unstructured":"Dixon-Suen, S. C., Nagle, C. M., Thrift, A. P., Pharoah, P. D. P., Ewing, A., Pearce, C. L. et al. Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study. Br. J. Cancer 118, 1123\u20131129 (2018).","journal-title":"Br. J. Cancer"},{"issue":"4 Pt 1","key":"492_CR40","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/0029-7844(96)00226-8","volume":"88","author":"JM Schildkraut","year":"1996","unstructured":"Schildkraut, J. M., Schwingl, P. J., Bastos, E., Evanoff, A. Hughes, C. Epithelial ovarian cancer risk among women with polycystic ovary syndrome. Obstet. Gynecol. 88(4 Pt 1), 554\u2013559 (1996).","journal-title":"Obstet. Gynecol."},{"key":"492_CR41","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1093\/aje\/kwm157","volume":"166","author":"SS Tworoger","year":"2007","unstructured":"Tworoger, S. S., Fairfield, K. M., Colditz, G. A., Rosner, B. A. Hankinson, S. E. Association of oral contraceptive use, other contraceptive methods, and infertility with ovarian cancer risk. Am. J. Epidemiol. 166, 894\u2013901 (2007).","journal-title":"Am. J. Epidemiol."},{"issue":"1","key":"492_CR42","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1001\/jamaoncol.2018.5188","volume":"5","author":"Weiyao Yin","year":"2019","unstructured":"Yin, W., Falconer, H., Yin, L., Xu, L. & Ye, W. Association between polycystic ovary syndrome and cancer risk. JAMA Oncol. https:\/\/doi.org\/10.1001\/jamaoncol.2018.5188 (2018).","journal-title":"JAMA Oncology"},{"key":"492_CR43","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1200\/JCO.2009.24.2057","volume":"28","author":"K Oktay","year":"2010","unstructured":"Oktay, K., Kim, J. Y., Barad, D. Babayev, S. N. Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast\/ovarian cancer risks. J. Clin. Oncol. 28, 240\u2013244 (2010).","journal-title":"J. Clin. Oncol."},{"key":"492_CR44","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.1200\/JCO.2016.67.4283","volume":"34","author":"NM Iyengar","year":"2016","unstructured":"Iyengar, N. M., Gucalp, A., Dannenberg, A. J. Hudis, C. A. Obesity and cancer mechanisms: tumor microenvironment and inflammation. J. Clin. Oncol. 34, 4270\u20134276 (2016).","journal-title":"J. Clin. Oncol."},{"key":"492_CR45","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/978-0-387-78818-0_10","volume":"630","author":"AH Eliassen","year":"2008","unstructured":"Eliassen, A. H. Hankinson, S. E. Endogenous hormone levels and risk of breast, endometrial and ovarian cancers: prospective studies. Adv. Exp. Med. Biol. 630, 148\u2013165 (2008).","journal-title":"Adv. Exp. Med. Biol."},{"key":"492_CR46","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1093\/jnci\/90.23.1774","volume":"90","author":"HA Risch","year":"1998","unstructured":"Risch, H. A. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J. Natl Cancer Inst. 90, 1774\u20131786 (1998).","journal-title":"J. Natl Cancer Inst."},{"key":"492_CR47","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/S1470-2045(13)70448-0","volume":"14","author":"M Widschwendter","year":"2013","unstructured":"Widschwendter, M., Rosenthal, A. N., Philpott, S., Rizzuto, I., Fraser, L., Hayward, J. et al. The sex hormone system in carriers of BRCA1\/2 mutations: a case-control study. Lancet Oncol. 14, 1226\u20131232 (2013).","journal-title":"Lancet Oncol."},{"key":"492_CR48","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1210\/jc.2006-2274","volume":"92","author":"A Jain","year":"2007","unstructured":"Jain, A., Polotsky, A. J., Rochester, D., Berga, S. L., Loucks, T., Zeitlian, G. et al. Pulsatile luteinizing hormone amplitude and progesterone metabolite excretion are reduced in obese women. J. Clin. Endocrinol. Metab. 92, 2468\u20132473 (2007).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"492_CR49","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1002\/(SICI)1097-0142(19970515)79:10<1944::AID-CNCR15>3.0.CO;2-V","volume":"79","author":"SZ Bu","year":"1997","unstructured":"Bu, S. Z., Yin, D. L., Ren, X. H., Jiang, L. Z., Wu, Z. J., Gao, Q. R. et al. Progesterone induces apoptosis and up-regulation of p53 expression in human ovarian carcinoma cell lines. Cancer 79, 1944\u20131950 (1997).","journal-title":"Cancer"},{"key":"492_CR50","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1093\/jnci\/94.1.32","volume":"94","author":"JM Schildkraut","year":"2002","unstructured":"Schildkraut, J. M., Calingaert, B., Marchbanks, P. A., Moorman, P. G. Rodriguez, G. C. Impact of progestin and estrogen potency in oral contraceptives on ovarian cancer risk. J. Natl Cancer Inst. 94, 32\u201338 (2002).","journal-title":"J. Natl Cancer Inst."},{"key":"492_CR51","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/jnci\/94.1.50","volume":"94","author":"GC Rodriguez","year":"2002","unstructured":"Rodriguez, G. C., Nagarsheth, N. P., Lee, K. L., Bentley, R. C., Walmer, D. K., Cline, M. et al. Progestin-induced apoptosis in the Macaque ovarian epithelium: differential regulation of transforming growth factor-beta. J. Natl Cancer Inst. 94, 50\u201360 (2002).","journal-title":"J. Natl Cancer Inst."},{"key":"492_CR52","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3109\/03014460.2010.507221","volume":"38","author":"FL Crowe","year":"2011","unstructured":"Crowe, F. L., Key, T. J., Allen, N. E., Appleby, P. N., Overvad, K., Gronbaek, H. et al. A cross-sectional analysis of the associations between adult height, BMI and serum concentrations of IGF-I and IGFBP-1 -2 and -3 in the European Prospective Investigation into Cancer and Nutrition (EPIC). Ann. Hum. Biol. 38, 194\u2013202 (2011).","journal-title":"Ann. Hum. Biol."},{"key":"492_CR53","doi-asserted-by":"publisher","first-page":"257058","DOI":"10.1155\/2010\/257058","volume":"2010","author":"MC Beauchamp","year":"2010","unstructured":"Beauchamp, M. C., Yasmeen, A., Knafo, A. Gotlieb, W. H. Targeting insulin and insulin-like growth factor pathways in epithelial ovarian cancer. J. Oncol. 2010, 257058 (2010).","journal-title":"J. Oncol."},{"key":"492_CR54","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nrc3215","volume":"12","author":"M Pollak","year":"2012","unstructured":"Pollak, M. The insulin and insulin-like growth factor receptor family in neoplasia: an update. Nat. Rev. Cancer 12, 159\u2013169 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"492_CR55","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/ijc.10613","volume":"101","author":"A Lukanova","year":"2002","unstructured":"Lukanova, A., Lundin, E., Toniolo, P., Micheli, A., Akhmedkhanov, A., Rinaldi, S. et al. Circulating levels of insulin-like growth factor-I and risk of ovarian cancer. Int. J. Cancer 101, 549\u2013554 (2002).","journal-title":"Int. J. Cancer"},{"key":"492_CR56","doi-asserted-by":"publisher","first-page":"e537","DOI":"10.1016\/S1470-2045(12)70362-5","volume":"13","author":"H Werner","year":"2012","unstructured":"Werner, H. Bruchim, I. IGF-1 and BRCA1 signalling pathways in familial cancer. Lancet Oncol. 13, e537\u2013e544 (2012).","journal-title":"Lancet Oncol."},{"key":"492_CR57","doi-asserted-by":"publisher","first-page":"3641","DOI":"10.1093\/hmg\/ddy271","volume":"27","author":"L Yengo","year":"2018","unstructured":"Yengo, L., Sidorenko, J., Kemper, K. E., Zheng, Z., Wood, A. R., Weedon, M. N. et al. Meta-analysis of genome-wide association studies for height and body mass index in approximately 700000 individuals of European ancestry. Hum. Mol. Genet. 27, 3641\u20133649 (2018).","journal-title":"Hum. Mol. Genet."},{"key":"492_CR58","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ajhg.2017.06.005","volume":"101","author":"PM Visscher","year":"2017","unstructured":"Visscher, P. M., Wray, N. R., Zhang, Q., Sklar, P., McCarthy, M. I., Brown, M. A. et al. 10 Years of GWAS discovery: biology, function, and translation. Am. J. Hum. Genet. 101, 5\u201322 (2017).","journal-title":"Am. J. Hum. Genet."}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41416-019-0492-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41416-019-0492-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41416-019-0492-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T22:40:11Z","timestamp":1721428811000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-019-0492-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,19]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["492"],"URL":"https:\/\/doi.org\/10.1038\/s41416-019-0492-8","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,19]]},"assertion":[{"value":"25 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"G.P. received honoraria and grant from Pfizer, Roche, Novartis, Accord, AstraZeneca, Amgen, Accord and Lilly. R.S. served on advisory board for Tesaro, Clovis, Astra Zeneca, Ethicon and Genmab, and speaker\u2019s bureau for Tesaro and Genentech. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The current work and all contributing studies in CIMBA received approval from the local institutional review board or ethics committee. Written informed consent was provided by all of the participants participating in each individual CIMBA study. The institutional committees that approved individual studies are listed in.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"CIMBA: The CIMBA data management and data analysis were supported by Cancer Research \u2013 UK grants C12292\/A20861, C12292\/A11174. ACA is a Cancer Research UK Senior Cancer Research Fellow. G.C.T. and A.B.S. are NHMRC Research Fellows. iCOGS: the European Community\u2019s Seventh Framework Programme under grant agreement No. 223175 (HEALTH-F2-2009-223175) (COGS), Cancer Research UK (C1287\/A10118, C1287\/A 10710, C12292\/A11174, C1281\/A12014, C5047\/A8384, C5047\/A15007, C5047\/A10692, C8197\/A16565), the National Institutes of Health (CA128978) and Post-Cancer GWAS initiative (1U19 CA148537, 1U19 CA148065 and 1U19 CA148112 - the GAME-ON initiative), the Department of Defence (W81XWH-10-1-0341), the Canadian Institutes of Health Research (CIHR) for the CIHR Team in Familial Risks of Breast Cancer (CRN-87521), and the Ministry of Economic Development, Innovation and Export Trade (PSR-SIIRI-701), Komen Foundation for the Cure, the Breast Cancer Research Foundation, and the Ovarian Cancer Research Fund. The PERSPECTIVE project was supported by the Government of Canada through Genome Canada and the Canadian Institutes of Health Research, the Ministry of Economy, Science and Innovation through Genome Qu\u00e9bec, and The Quebec Breast Cancer Foundation. BCFR: UM1 CA164920 from the National Cancer Institute. The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating centres in the Breast Cancer Family Registry (BCFR), nor does mention of trade names, commercial products, or organisations imply endorsement by the US Government or the BCFR. BFBOCC: Lithuania (BFBOCC-LT): Research Council of Lithuania grant SEN-18\/2015. BIDMC: Breast Cancer Research Foundation. BMBSA: Cancer Association of South Africa (PI Elizabeth J. van Rensburg). CNIO: Spanish Ministry of Health PI16\/00440 supported by FEDER funds, the Spanish Ministry of Economy and Competitiveness (MINECO) SAF2014-57680-R and the Spanish Research Network on Rare diseases (CIBERER). COH-CCGCRN: Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under grant number R25CA112486, and RC4CA153828 (PI: J. Weitzel) from the National Cancer Institute and the Office of the Director, National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. CONSIT: Associazione Italiana Ricerca sul Cancro (AIRC; IG2014 no.15547) to P. Radice. Italian Association for Cancer Research (AIRC; grant no.16933) to L. Ottini. Associazione Italiana Ricerca sul Cancro (AIRC; IG2015 no.16732) to P.P. J.A. is supported by funds from Italian citizens who allocated the 5\u2009\u00d7\u20091000 share of their tax payment in support of the Fondazione IRCCS Istituto Nazionale Tumori, according to Italian laws (INT-Institutional strategic projects \u20185\u2009\u00d7\u20091000\u2019). DEMOKRITOS: European Union (European Social Fund \u2013 ESF) and Greek national funds through the Operational Program \u2018Education and Lifelong Learning\u2019 of the National Strategic Reference Framework (NSRF) - Research Funding Program of the General Secretariat for Research & Technology: SYN11_10_19 NBCA. Investing in knowledge society through the European Social Fund. DFKZ: German Cancer Research Center. EMBRACE: Cancer Research UK Grants C1287\/A10118 and C1287\/A11990. D.G.E. and F.L. are supported by an NIHR grant to the Biomedical Research Centre, Manchester. The Investigators at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust are supported by an NIHR grant to the Biomedical Research Centre at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust. R.E. and E.B. are supported by Cancer Research UK Grant C5047\/A8385. R.E. is also supported by NIHR support to the Biomedical Research Centre at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust. FCCC: The University of Kansas Cancer Center (P30 CA168524) and the Kansas Bioscience Authority Eminent Scholar Program. A.K.G. was funded by R0 1CA140323, R01 CA214545, and by the Chancellors Distinguished Chair in Biomedical Sciences Professorship. FPGMX: FISPI05\/2275 and Mutua Madrile\u00f1a Foundation (FMMA). GC-HBOC: German Cancer Aid (grant no. 110837, R.K.S.). GEMO: Ligue Nationale Contre le Cancer; the Association \u2018Le cancer du sein, parlons-en!\u2019 Award, the Canadian Institutes of Health Research for the \u2018CIHR Team in Familial Risks of Breast Cancer\u2019 program and the French National Institute of Cancer (INCa grants 2013-1-BCB-01-ICH-1 and SHS-E-SP 18-015). GEORGETOWN: The Non-Therapeutic Subject Registry Shared Resource at Georgetown University (NIH\/NCI grant P30-CA051008), the Fisher Center for Hereditary Cancer and Clinical Genomics Research, and Swing Fore the Cure. G-FAST: Bruce Poppe is a senior clinical investigator of FWO. Mattias Van Heetvelde obtained funding from IWT. HCSC: Spanish Ministry of Health PI15\/00059, PI16\/01292, and CB-161200301 CIBERONC from ISCIII (Spain), partially supported by European Regional Development FEDER funds. HEBCS: Helsinki University Hospital Research Fund, the Finnish Cancer Society and the Sigrid Juselius Foundation. HEBON: the Dutch Cancer Society grants NKI1998-1854, NKI2004-3088, NKI2007-3756, the Netherlands Organisation of Scientific Research grant NWO 91109024, the Pink Ribbon grants 110005 and 2014-187.WO76, the BBMRI grant NWO 184.021.007\/CP46 and the Transcan grant JTC 2012 Cancer 12-054. HRBCP: Hong Kong Sanatorium and Hospital, Dr Ellen Li Charitable Foundation, The Kerry Group Kuok Foundation, National Institute of Health1R 03CA130065, and North California Cancer Center. HUNBOCS: Hungarian Research Grants KTIA-OTKA CK-80745 and OTKA K-112228. ICO: The authors would like to particularly acknowledge the support of the Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer (AECC), the Instituto de Salud Carlos III (organismo adscrito al Ministerio de Econom\u00eda y Competitividad) and \u201cFondo Europeo de Desarrollo Regional (FEDER), una manera de hacer Europa\u201d (PI10\/01422, PI13\/00285, PIE13\/00022, PI15\/00854, PI16\/00563 and CIBERONC) and the Institut Catal\u00e0 de la Salut and Autonomous Government of Catalonia (2009SGR290, 2014SGR338 and PERIS Project MedPerCan). IHCC: PBZ_KBN_122\/P05\/2004. ILUH: Icelandic Association \u2018Walking for Breast Cancer Research\u2019 and by the Landspitali University Hospital Research Fund. INHERIT: Canadian Institutes of Health Research for the \u201cCIHR Team in Familial Risks of Breast Cancer\u201d program \u2013 grant # CRN-87521 and the Ministry of Economic Development, Innovation and Export Trade \u2013 grant # PSR-SIIRI-701. IOVHBOCS: Ministero della Salute and \u20185\u2009\u00d7\u20091000\u2019 Istituto Oncologico Veneto grant. IPOBCS: Liga Portuguesa Contra o Cancro. kConFab: The National Breast Cancer Foundation, and previously by the National Health and Medical Research Council (NHMRC), the Queensland Cancer Fund, the Cancer Councils of New South Wales, Victoria, Tasmania and South Australia, and the Cancer Foundation of Western Australia. MAYO: NIH grants CA116167, CA192393 and CA176785, an NCI Specialized Program of Research Excellence (SPORE) in Breast Cancer (CA116201), and a grant from the Breast Cancer Research Foundation. MCGILL: Jewish General Hospital Weekend to End Breast Cancer, Quebec Ministry of Economic Development, Innovation and Export Trade. M.T. is supported by the European Union Seventh Framework Program (2007Y2013)\/European Research Council (Grant No. 310018). MODSQUAD: MH CZ - DRO (MMCI, 00209805), MEYS - NPS I - LO1413 to L.F. and by Charles University in Prague project UNCE204024 (to M.Z.). MSKCC: The Breast Cancer Research Foundation, the Robert and Kate Niehaus Clinical Cancer Genetics Initiative, the Andrew Sabin Research Fund and a Cancer Center Support Grant\/Core Grant (P30 CA008748). NAROD: 1R01 CA149429-01. NCI: The Intramural Research Program of the US National Cancer Institute, NIH, and by support services contracts NO2-CP-11019-50, N02-CP-21013-63 and N02-CP-65504 with Westat, Inc, Rockville, MD. NICCC: Clalit Health Services in Israel, the Israel Cancer Association and the Breast Cancer Research Foundation (BCRF), NY. NNPIO: the Russian Foundation for Basic Research (grants 17-54-12007, 17-00-00171 and 18-515-12007). NRG Oncology: U10 CA180868, NRG SDMC grant U10 CA180822, NRG Administrative Office and the NRG Tissue Bank (CA 27469), the NRG Statistical and Data Center (CA 37517) and the Intramural Research Program, NCI. OSUCCG: Ohio State University Comprehensive Cancer Center. PBCS: Italian Association of Cancer Research (AIRC) [IG 2013 N.14477] and Tuscany Institute for Tumors (ITT) grant 2014-2015-2016. SEABASS: Ministry of Science, Technology and Innovation, Ministry of Higher Education (UM.C\/HlR\/MOHE\/06) and Cancer Research Initiatives Foundation. SMC: the Israeli Cancer Association. SWE-BRCA: the Swedish Cancer Society. UCHICAGO: NCI Specialized Program of Research Excellence (SPORE) in Breast Cancer (CA125183), R01 CA142996, 1U01CA161032, P20CA233307, R01 CA228198,\u00a0American Cancer Society (MRSG-13-063-01-TBG, CRP-10-119-01-CCE), Breast Cancer Research Foundation, Susan G. Komen Foundation (SAC110026), and Ralph and Marion Falk Medical Research Trust, the Entertainment Industry Fund National Women\u2019s Cancer Research Alliance. F.Q. was supported by the Alpha Omega Alpha Carolyn L. Cuckein Student Research Fellowship. UCLA: Jonsson Comprehensive Cancer Center Foundation; Breast Cancer Research Foundation. UCSF: UCSF Cancer Risk Program and Helen Diller Family Comprehensive Cancer Center. UKFOCR: Cancer Research UK. UPENN: Breast Cancer Research Foundation; Susan G. Komen Foundation for the cure, Basser Center for BRCA. UPITT\/MWH: Hackers for Hope Pittsburgh. VFCTG: Victorian Cancer Agency, Cancer Australia, National Breast Cancer Foundation. WCP: B.Y.K. is funded by the American Cancer Society Early Detection Professorship (SIOP-06-258-01-COUN) and the National Center for Advancing Translational Sciences (NCATS), Grant UL1TR000124.\u00a0D.G.E. is supported by the Manchester NIHR Biomedical Research Centre (IS-BRC-1215-20007).\u00a0TOR: H.R. is funed by NCI, R01 CA063682.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Owing to the sensitive nature of the data used in this study, data requests by researchers trained in maintaining human subject confidentiality may be directed to the corresponding author of this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Note"}}]}}